Cardiovascular Implantable Electronic Device Leads in CKD and ESRD Patients: Review and Recommendations for Practice

Theodore F. Saad, Dirk M. Hentschel, Bruce Koplan, Haimanot Wasse, Arif Asif, Daniel V. Patel, Loay Salman, Roger Carrillo, Jeff Hoggard

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Cardiovascular implantable electronic devices (CIEDs) are frequently utilized for management of cardiac dysrhythmias in patients with chronic kidney disease or end-stage renal disease receiving hemodialysis. The survival benefit from use of implantable cardioverter defibrillators in patients with CKD or ESRD is not as clear as in the general population, particularly when used for primary prevention of sudden cardiac death. Transvenous CIED leads are associated with central vein stenosis resulting in significant adverse consequences for existing or future arteriovenous access. Venous hypertension from CIED lead-related central vein stenosis is a challenging clinical problem and may require repeated percutaneous interventions, replacement of the CIED, or creation of alternative arteriovenous access. Infections associated with transvenous CIED leads are more frequent and associated with worse outcomes in patients with renal disease. Epicardial CIED leads or other nontransvenous devices may reduce complications of both central venous stenosis and endovascular infection in these vulnerable patients. Consensus recommendations are offered for avoidance and management of complications arising from the use of CIEDs and arteriovenous hemodialysis access.

Original languageEnglish
Pages (from-to)114-123
Number of pages10
JournalSeminars in Dialysis
Volume26
Issue number1
DOIs
StatePublished - Jan 1 2013

Fingerprint

Chronic Kidney Failure
Equipment and Supplies
Pathologic Constriction
Renal Dialysis
Veins
Implantable Defibrillators
Sudden Cardiac Death
Primary Prevention
Infection
Chronic Renal Insufficiency
Cardiac Arrhythmias
Hypertension
Kidney
Survival
Population

ASJC Scopus subject areas

  • Nephrology

Cite this

Cardiovascular Implantable Electronic Device Leads in CKD and ESRD Patients : Review and Recommendations for Practice. / Saad, Theodore F.; Hentschel, Dirk M.; Koplan, Bruce; Wasse, Haimanot; Asif, Arif; Patel, Daniel V.; Salman, Loay; Carrillo, Roger; Hoggard, Jeff.

In: Seminars in Dialysis, Vol. 26, No. 1, 01.01.2013, p. 114-123.

Research output: Contribution to journalArticle

Saad, TF, Hentschel, DM, Koplan, B, Wasse, H, Asif, A, Patel, DV, Salman, L, Carrillo, R & Hoggard, J 2013, 'Cardiovascular Implantable Electronic Device Leads in CKD and ESRD Patients: Review and Recommendations for Practice', Seminars in Dialysis, vol. 26, no. 1, pp. 114-123. https://doi.org/10.1111/j.1525-139X.2012.01103.x
Saad, Theodore F. ; Hentschel, Dirk M. ; Koplan, Bruce ; Wasse, Haimanot ; Asif, Arif ; Patel, Daniel V. ; Salman, Loay ; Carrillo, Roger ; Hoggard, Jeff. / Cardiovascular Implantable Electronic Device Leads in CKD and ESRD Patients : Review and Recommendations for Practice. In: Seminars in Dialysis. 2013 ; Vol. 26, No. 1. pp. 114-123.
@article{9f25c52ee2fb42988086697de6471ce4,
title = "Cardiovascular Implantable Electronic Device Leads in CKD and ESRD Patients: Review and Recommendations for Practice",
abstract = "Cardiovascular implantable electronic devices (CIEDs) are frequently utilized for management of cardiac dysrhythmias in patients with chronic kidney disease or end-stage renal disease receiving hemodialysis. The survival benefit from use of implantable cardioverter defibrillators in patients with CKD or ESRD is not as clear as in the general population, particularly when used for primary prevention of sudden cardiac death. Transvenous CIED leads are associated with central vein stenosis resulting in significant adverse consequences for existing or future arteriovenous access. Venous hypertension from CIED lead-related central vein stenosis is a challenging clinical problem and may require repeated percutaneous interventions, replacement of the CIED, or creation of alternative arteriovenous access. Infections associated with transvenous CIED leads are more frequent and associated with worse outcomes in patients with renal disease. Epicardial CIED leads or other nontransvenous devices may reduce complications of both central venous stenosis and endovascular infection in these vulnerable patients. Consensus recommendations are offered for avoidance and management of complications arising from the use of CIEDs and arteriovenous hemodialysis access.",
author = "Saad, {Theodore F.} and Hentschel, {Dirk M.} and Bruce Koplan and Haimanot Wasse and Arif Asif and Patel, {Daniel V.} and Loay Salman and Roger Carrillo and Jeff Hoggard",
year = "2013",
month = "1",
day = "1",
doi = "10.1111/j.1525-139X.2012.01103.x",
language = "English",
volume = "26",
pages = "114--123",
journal = "Seminars in Dialysis",
issn = "0894-0959",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Cardiovascular Implantable Electronic Device Leads in CKD and ESRD Patients

T2 - Review and Recommendations for Practice

AU - Saad, Theodore F.

AU - Hentschel, Dirk M.

AU - Koplan, Bruce

AU - Wasse, Haimanot

AU - Asif, Arif

AU - Patel, Daniel V.

AU - Salman, Loay

AU - Carrillo, Roger

AU - Hoggard, Jeff

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Cardiovascular implantable electronic devices (CIEDs) are frequently utilized for management of cardiac dysrhythmias in patients with chronic kidney disease or end-stage renal disease receiving hemodialysis. The survival benefit from use of implantable cardioverter defibrillators in patients with CKD or ESRD is not as clear as in the general population, particularly when used for primary prevention of sudden cardiac death. Transvenous CIED leads are associated with central vein stenosis resulting in significant adverse consequences for existing or future arteriovenous access. Venous hypertension from CIED lead-related central vein stenosis is a challenging clinical problem and may require repeated percutaneous interventions, replacement of the CIED, or creation of alternative arteriovenous access. Infections associated with transvenous CIED leads are more frequent and associated with worse outcomes in patients with renal disease. Epicardial CIED leads or other nontransvenous devices may reduce complications of both central venous stenosis and endovascular infection in these vulnerable patients. Consensus recommendations are offered for avoidance and management of complications arising from the use of CIEDs and arteriovenous hemodialysis access.

AB - Cardiovascular implantable electronic devices (CIEDs) are frequently utilized for management of cardiac dysrhythmias in patients with chronic kidney disease or end-stage renal disease receiving hemodialysis. The survival benefit from use of implantable cardioverter defibrillators in patients with CKD or ESRD is not as clear as in the general population, particularly when used for primary prevention of sudden cardiac death. Transvenous CIED leads are associated with central vein stenosis resulting in significant adverse consequences for existing or future arteriovenous access. Venous hypertension from CIED lead-related central vein stenosis is a challenging clinical problem and may require repeated percutaneous interventions, replacement of the CIED, or creation of alternative arteriovenous access. Infections associated with transvenous CIED leads are more frequent and associated with worse outcomes in patients with renal disease. Epicardial CIED leads or other nontransvenous devices may reduce complications of both central venous stenosis and endovascular infection in these vulnerable patients. Consensus recommendations are offered for avoidance and management of complications arising from the use of CIEDs and arteriovenous hemodialysis access.

UR - http://www.scopus.com/inward/record.url?scp=84872967990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872967990&partnerID=8YFLogxK

U2 - 10.1111/j.1525-139X.2012.01103.x

DO - 10.1111/j.1525-139X.2012.01103.x

M3 - Article

C2 - 22891983

AN - SCOPUS:84872967990

VL - 26

SP - 114

EP - 123

JO - Seminars in Dialysis

JF - Seminars in Dialysis

SN - 0894-0959

IS - 1

ER -